Exscientia

📍 Oxford, United Kingdom🗓 Founded 2012👥 489 employees💰 Last funded Apr 2021
Biotechnology Research🌐 exscientia.ai
Website LinkedIn
Exscientia is a global pharmatech company using patient-first artificial intelligence (AI) to discover better drugs, faster. Our mission is to encode, automate and transform every stage of the drug design and development process, by combining the latest AI techniques with experimental innovation, to enable the design of patient centric drug candidates with an improved probability of success. Our validated platform has delivered the first three AI-designed drugs to enter clinical trials and is the first AI system proven to improve clinical outcomes in oncology. We’ve significantly accelerated pre-clinical drug discovery, with 10x productivity improvement in delivering a drug candidate compared with industry standards. By actively applying AI to precision engineer medicines more rapidly and efficiently, we allow the best ideas of science to rapidly become the best medicines for patients.
4
Total investors
0
Early stage
0
Mid stage
4
Late stage
2012
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
3
United States
1
Investor activity2020–2021 · investors recorded per year
2020120213
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Exscientia?
Exscientia has 4 investors on record on gritt.io and 4 late-stage investors.
When did Exscientia last raise funding?
The most recent investment in Exscientia recorded on gritt.io was in April 2021.
When was Exscientia founded?
Exscientia was founded in 2012.
What industry is Exscientia in?
Exscientia operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Exscientia based?
Exscientia is headquartered in Oxford, United Kingdom.